Clinical trial
Sickle-Cell Disease: Neuroimaging and Cognitive Decline
NCT00451919 is registered in ClinicalTrials.gov with National Heart, Lung, and Blood Institute (NHLBI) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Sickle-Cell Disease: Neuroimaging and Cognitive Decline
- Lead sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 31, 2006
- Completion date
- February 28, 2009
- Enrollment
- 120 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
sickle cell disease